Citius Oncology Unveils AI-Powered Platform to Drive LYMPHIR™ Launch for CTCL
Citius Oncology, Inc. (“Citius Oncology”) the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. (“Citius Pharma”) (Nasdaq: CTXR), a late-stage biopharmaceutical company advancing first-in-class critical care therapies, announced the deployment of a cutting-edge AI-driven platform to empower its commercial operations ahead of…




























